Refined Disease Risk Index for Hematological Malignancies, Including Rare Disorders, After Allogeneic Stem Cell Transplantation.
Fujiwara S, Hattori N, Matsui T, Nakata A, Sasaki Y, Shimada S, Murai S, Abe M, Baba Y, Watanuki M, Kawaguchi Y, Arai N, Kabasawa N, Tsukamoto H, Uto Y, Yanagisawa K, Harada H, Nakamaki T.
Fujiwara S, et al. Among authors: hattori n.
Transplant Proc. 2019 Dec;51(10):3437-3443. doi: 10.1016/j.transproceed.2019.08.044. Epub 2019 Nov 14.
Transplant Proc. 2019.
PMID: 31733801